Evidence map›Paper›PMID 28840147›Full record

ArticleOrthopaedic journal of sports medicine2017

Perioperative Testosterone Supplementation Increases Lean Mass in Healthy Men Undergoing Anterior Cruciate Ligament Reconstruction: A Randomized Controlled Trial.

Brian Wu, Dan Lorezanza, Ido Badash, Max Berger, Christianne Lane, Jonathan C Sum, George F Hatch, E Todd Schroeder

6 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in Orthopaedic journal of sports medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 6 registered trials, which are not on this map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01595581 phase3completednot on this map

The Effects of Acute Testosterone Administration in Men on Muscle Mass, Strength, and Physical Function Following ACL Reconstructive Surgery

TypeinterventionalSponsorUniversity of Southern CaliforniaRan2012 to 2015Enrolled14ConditionsMuscle Atrophy, ACL Reconstruction, Trauma, OsteoarthritisArmsTestosterone, Placebo
NCT04456530 phase2 / phase3unknown statusnot on this mapstarted 2020, after this paper: background citation

Use of Testosterone to Prevent Post-Surgical Muscle Loss - Pilot Study

TypeinterventionalSponsorThe Stone Research Foundation for Sports Medicine and ArthritisRan2020 to 2022Enrolled15ConditionsMuscle Atrophy, Surgery, Knee Injuries and Disorders, Complication of Surgical ProcedureArmsAveed 750 MG in 3 ML IM Injection, Normal Saline 3 ML IM Injection
NCT05367284 unknown statusnot on this mapstarted 2022, after this paper: background citation

Use of Perioperative Testosterone Replacement Therapy (TRT) in Sarcopenic Male Colorectal Cancer Patients - A Single Arm Open Label Feasibility Study

TypeobservationalSponsorLondon North West Healthcare NHS TrustRan2022 to 2023Enrolled30ConditionsColorectal Cancer, Sarcopenia, Hypogonadism, Male, Perioperative CareArmsTestosterone
NCT06462482 phase4not yet recruitingnot on this mapstarted 2025, after this paper: background citation

Peri-Operative Testosterone Administration in Primary Hip Arthroscopy

TypeinterventionalSponsorAmerican Hip InstituteRan2025 to 2026Enrolled60ConditionsFemoro Acetabular ImpingementArmsNandrolone Decanoate, Saline
NCT06608914 phase4not yet recruitingnot on this mapstarted 2025, after this paper: background citation

Peri-Operative Testosterone Administration in Primary Total Hip Arthroplasty

TypeinterventionalSponsorAmerican Hip InstituteRan2025 to 2026Enrolled60ConditionsOsteoarthritis, HipArmsNandrolone decanoate, Saline
NCT06974526 phase2recruitingnot on this mapstarted 2025, after this paper: background citation

Randomized, Multicenter, Double-blind, Parallel, Placebo-controlled Study to Investigate the Safety and Exploratory Efficacy of the Oxandrolone Subdermal Bioabsorbable Implant as an Adjuvant Treatment in Rehabilitation Following Anterior Cruciate Ligament (ACL) Surgical Reconstruction (IMOX Study)

TypeinterventionalSponsorScience Valley Research InstituteRan2025 to 2027Enrolled96ConditionsAnterior Cruciate Ligament (ACL) ReconstructionArmsOxandrolone, Placebo
3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it, 24 citations in OpenAlex.

  1. Anabolic Androgenic Steroids in Orthopaedic Surgery: Current Concepts and Clinical Applications.Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews · 2022
    Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Testosterone replacement therapy and bladder cancer.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2025
    Review
  7. Article
  8. Article
  9. Review
  10. Hypogonadism and urologic surgeries: a narrative review.Translational andrology and urology · 2022
    Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Brian WuKeck School of Medicine, University of Southern California, Los Angeles, California, USA.
Dan LorezanzaKeck School of Medicine, University of Southern California, Los Angeles, California, USA.
Ido BadashKeck School of Medicine, University of Southern California, Los Angeles, California, USA.
Max BergerKeck School of Medicine, University of Southern California, Los Angeles, California, USA.
Christianne LaneKeck School of Medicine, University of Southern California, Los Angeles, California, USA.
Jonathan C SumKeck School of Medicine, University of Southern California, Los Angeles, California, USA.
George F HatchKeck School of Medicine, University of Southern California, Los Angeles, California, USA.
E Todd SchroederKeck School of Medicine, University of Southern California, Los Angeles, California, USA.
University of Southern California · US

Funding

Southern California Clinical and Translational Science InstituteUL1TR001855 · NCATS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Thomas A Buchanan, Michele D. Kipke · 2016 to 2026
$81.3M
NCATS NIH HHS UL1 TR001855
6 · The paper itself

Abstract

backgroundRehabilitation after repair of the anterior cruciate ligament (ACL) is complicated by the loss of leg muscle mass and strength. Prior studies have shown that preoperative rehabilitation may improve muscle strength and postoperative outcomes. Testosterone supplementation may likewise counteract this muscle loss and potentially improve clinical outcomes. PURPOSE: The purpose was to investigate the effect of perioperative testosterone administration on lean mass after ACL reconstruction in men and to examine the effects of testosterone on leg strength and clinical outcome scores. It was hypothesized that testosterone would increase lean mass and leg strength and improve clinical outcome scores relative to placebo. STUDY

designRandomized controlled trial; Level of evidence, 1.

methodsMale patients (N = 13) scheduled for ACL reconstruction were randomized into 2 groups: testosterone and placebo. Participants in the testosterone group received 200 mg of intramuscular testosterone weekly for 8 weeks beginning 2 weeks before surgery. Participants in the placebo group received saline following the same schedule. Both groups participated in a standard rehabilitation protocol. The primary outcome was the change in total lean body mass at 6 and 12 weeks. Secondary outcomes were extensor muscle strength, Tegner activity score, and Knee injury and Osteoarthritis Outcome Score.

resultsThere was an increase in lean mass of a mean 2.7 ± 1.7 kg at 6 weeks postoperatively in the testosterone group compared with a decrease of a mean 0.1 ± 1.5 kg in the placebo group (

conclusionPerioperative testosterone supplementation increased lean mass 6 weeks after ACL reconstruction, suggesting that this treatment may help minimize the effects of muscle atrophy associated with ACL injuries and repair. This study was not powered to detect differences in strength or clinical outcome scores to assess the incidence of testosterone-related adverse events. CLINICAL RELEVANCE: Supraphysiological testosterone supplementation may be a useful adjunct therapy for counteracting muscle atrophy after ACL reconstruction. Further investigation is necessary to determine the safety profile and effects of perioperative testosterone administration on leg strength and clinical outcomes after surgery. REGISTRATION: NCT01595581 (ClinicalTrials.gov).

Indexed as

anterior cruciate ligament reconstructionlean massrandomized controlled trialrehabilitationtestosterone

Identifiers

PMID28840147
PMCPMC5555502
OpenAlexW2743894245

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.